New Path Molecular Research Ltd
- Active
- Micro
- 11 years
- 5 employees
- £285,814 (cur assets)
- 0-1m
- Real address
- 4 directors
- 1 owner
- Cambridge
Two conditions of three:
1.Turnover < £632,000
2.Balance sheet total < £316,000
3.Average number of employees < 10
Field of Operation
Summary
New Path Molecular Research Ltd is a private limited company registered in England/Wales with the registration number 09412383. The company was founded eleven years ago on January 29, 2015, and registered at CB22 3AT, England, Cambridge, Cambridgeshire, Building 580 Babraham Research Campus. The address is probably real as only one company are registered at the same address. Its status is active. The company operates in the professional services, the scientific and technical r&d industries. Officially, it has one owner or PSCs, four directors, and five employees.
It's a micro company as it met two conditions of three: turnover less than £632,000, balance sheet total less than £316,000, employees less than 10. The last reported current assets is £285,814.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Owners & PSC
-
Individual
- 10 years
- 25%+
-
Resident of United Kingdom
Managers
-
Individual
- 9 years
-
Resident of United Kingdom
-
Individual
- 11 years
- 6
-
Resident of United Kingdom
-
Individual
- 11 years
-
Resident of United Kingdom
-
Individual
- 11 years
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted five months ago.
Last news
-
Statement of capital following an allotment of shares on 2026-04-14Download 3 pages pdf report
-
legacyDownload 4 pages pdf report
-
Statement of capital following an allotment of shares on 2026-03-01Download 4 pages pdf report
FAQ about New Path Molecular Research Ltd
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.